Correction: Mukherjee Et Al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. 2023, , 510
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The authors would like to make the following corrections to this published paper [...].
Citing Articles
Mukherjee A, Wanjari U, Gopalakrishnan A, Kannampuzha S, Murali R, Namachivayam A Vaccines (Basel). 2024; 12(9).
PMID: 39340118 PMC: 11435671. DOI: 10.3390/vaccines12090996.
Domingo J Arch Toxicol. 2024; 98(11):3603-3617.
PMID: 39225797 PMC: 11489230. DOI: 10.1007/s00204-024-03854-8.
References
1.
Piscoya A, Ng-Sueng L, Parra Del Riego A, Cerna-Viacava R, Pasupuleti V, Roman Y
. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis. PLoS One. 2020; 15(12):e0243705.
PMC: 7728272.
DOI: 10.1371/journal.pone.0243705.
View
2.
Guo J, Sheng K, Wu S, Chen H, Xu W
. An Update on the Relationship of SARS-CoV-2 and Male Reproduction. Front Endocrinol (Lausanne). 2021; 12:788321.
PMC: 8649688.
DOI: 10.3389/fendo.2021.788321.
View
3.
Mukherjee A, Wanjari U, Gopalakrishnan A, Kannampuzha S, Murali R, Namachivayam A
. Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. 2023, , 510. Vaccines (Basel). 2024; 12(9).
PMC: 11435671.
DOI: 10.3390/vaccines12090996.
View